FOSRENOL 750 mg, chewable tablet 90 tablets
Active ingredients: Lanthanum, Lanthanum carbonate hydrate
Commercialized according to BDPMDispensing in France: Prescription only
Chewable tablet90 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- FOSRENOL 750 mg, comprimé à croquer
- Pharmaceutical form
- comprimé à croquer
- Route of administration
- orale
- Presentation description
- flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 90 comprimé(s)
- Marketing authorisation holder
- TAKEDA PHARMACEUTICALS INTERNATIONAL (IRLANDE)
- Reimbursement according to BDPM
- 65%
- Reimbursement conditions
- Ce médicament peut-être pris en charge ou remboursé par l'Assurance Maladie dans le cas suivant :<br><br>- Contrôle de l'excès de phosphates sanguins chez les patients présentant une insuffisance rénale chronique sous dialyse, en traitement de seconde intention ; JOURNAL OFFICIEL ; 28/06/13
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Sept 2006
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65651521CIP73692837CIP133400936928374Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LANTHANE (CARBONATE DE) HYDRATÉcomprimé | — | SA |
| LANTHANEcomprimé | 750 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.